F. Ferrando

A. Estellés, J. Aznar, A. Vayá, 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Is Family History Sufficient to Identify Women with Risk of Venous Thromboembolism Before Commencing the Contraceptive Pill?

J. Aznar, A. Vayá, Y. Mira, 2002, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Factor XIII deficiency in two Spanish families with a novel variant in gene F13A1 detected by next-generation sequencing; symptoms and clinical management

J. Cervera, A. Cid, A. Moret, 2020, Journal of Thrombosis and Thrombolysis.

Rheological behaviour of red blood cells in beta and deltabeta thalassemia trait.

P. Bolufer, I. Moreno, C. Falcó, 2003, Clinical hemorheology and microcirculation.

Increase in Thrombin Generation after Coronary Thrombolysis with rt-PA or Streptokinase with Simultaneous Heparin versus Heparin Alone

J. Aznar, P. Villa, V. Vila, 1998, Pathophysiology of Haemostasis and Thrombosis.

Effects of oral anticoagulant therapy and haplotype 1 of the endothelial protein C receptor gene on activated protein C levels

R. Bertina, F. España, A. Estellés, 2012, Thrombosis and Haemostasis.

Association of the Thrombomodulin Gene c.1418C>T Polymorphism With Thrombomodulin Levels and With Venous Thrombosis Risk

R. Bertina, F. España, A. Estellés, 2013, Arteriosclerosis, thrombosis, and vascular biology.

Hemorheological alterations and hypercoagulable state in deep vein thrombosis.

J. Aznar, A. Vayá, Y. Mira, 1998, Clinical hemorheology and microcirculation.

Spontaneous Renal Subcapsular Hematomain an Anticoagulated Patient

J. Aznar, A. Vayá, Y. Mira, 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Detection of low levels of lupus anticoagulant antibodies.

J. Aznar, A. Vayá, Y. Mira, 2005, Thrombosis research.

Management of a Patient With Calciphylaxis and Requiring Anticoagulant Therapy

A. Vayá, Y. Mira, F. Ferrando, 2007 .

Increase of Neutrophil Activation Markers in Venous Thrombosis—Contribution of Circulating Activated Protein C

F. España, D. Hervás, S. Bonanad, 2020, International journal of molecular sciences.

Sneddon's syndrome and antiphospholipid antibodies.

A. Estellés, J. Aznar, P. Villa, 1993, Thrombosis research.

Quantification of D-dimer using a new fully automated assay: its application for the diagnosis of deep vein thrombosis.

J. Aznar, A. Vayá, Y. Mira, 2000, Haematologica.

Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic risk

Justo Aznar, R. Bertina, F. España, 2004, Thrombosis and Haemostasis.

Rheological behaviour of red blood cells in β and δβ thalassemia trait

P. Bolufer, I. Moreno, C. Falcó, 2003 .

PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects

Justo Aznar, F. España, A. Estellés, 2000 .

Intracardiac thrombosis in a case of Behcet's disease associated with the prothrombin 20210G-A mutation.

A. Estellés, J. Aznar, A. Vayá, 2000, Haematologica.

JAK2V617F mutation as a marker of a latent myeloproliferative disorder in a patient with Budd-Chiari syndrome and factor V Leiden mutation

A. Vayá, Y. Mira, F. Orbis, 2007, Thrombosis and Haemostasis.

Elevated High Molecular Weight Fibrinogen in Plasma Is Predictive of Coronary Ischemic Events after Acute Myocardial Infarction

J. Aznar, V. Vila, E. Réganon, 1999, Thrombosis and Haemostasis.

Is Yasmin as Safe as Other Contraceptive Pills?

J. Aznar, A. Vayá, Y. Mira, 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Transient ischaemic attack associated with the new contraceptive Yasmin.

J. Aznar, A. Vayá, Y. Mira, 2003, Thrombosis research.

Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency

J. González-Porras, F. España, A. Vayá, 2019, Thrombosis and Haemostasis.

Clinical and molecular characterization by next generation sequencing of Spanish patients affected by congenital deficiencies of fibrinogen.

J. Cervera, A. Cid, A. Moret, 2019, Thrombosis research.

Does obesity constitute a risk factor for upper-extremity deep vein thrombosis?

D. Corella, J. Aznar, A. Vayá, 2005, Thrombosis and Haemostasis.

Next generation sequencing in bleeding disorders: two novel variants in the F5 gene (Valencia-1 and Valencia-2) associated with mild factor V deficiency

J. Cervera, A. Cid, A. Moret, 2019, Journal of Thrombosis and Thrombolysis.

Effective and Safe Management of Oral Anticoagulation Therapy in Patients Who Use the Internet-Accessed Telecontrol Tool SintromacWeb

Y. Mira, Fernando Ferrando, Yolanda Mira, 2015, Interactive journal of medical research.

Effective and Safe Management of Oral Anticoagulation Therapy in Patients Who Use the Internet-Accessed Telecontrol Tool SintromacWeb (e10)

Y. Mira, F. Ferrando, 2021 .

Pharmacogenetics of acenocoumarol in patients with extreme dose requirements

V. Vicente, V. Pérez-Andreu, N. García-Barberá, 2010, Journal of thrombosis and haemostasis : JTH.

Homocysteine levels in patients with deep vein thrombosis lacking thrombophilic defects

D. Corella, A. Vayá, Y. Mira, 2008, Thrombosis and Haemostasis.